DOJ, CDC FIGHT BACK AGAINST LIFTING MASK MANDATE — The Department of Justice said it was appealing a Florida court ruling that ended the travel mask mandate. This comes after the Centers for Disease Control and Prevention said the mandate was still necessary to protect Americans' health and the agency's authority. The decision follows two fraught days of debate in the White House as officials weighed the political risks of continuing a popular but controversial travel mask mandate against rising Covid-19 cases and the potential threat the ruling posed to the CDC's ability to issue future mandates. In the end, the CDC evidently decided that the risk of the sweeping ruling was too high for both Americans' health and the precedent it might set in questioning the agency's authority, such as mandating masks, during public health emergencies. "It is essential that CDC ensures its authority to protect the public's health," Georges Benjamin, executive director of the American Public Health Association, told POLITICO. "The judge's decision is so poorly reasoned and just plain wrong. It needs a more experienced juridical review." What's next: The court's injunction against the mandate remains in place for now. The DOJ filed a notice of appeal to the Florida court on Wednesday, according to a department spokesperson, and could ask the court to stay the judge's injunction while the case proceeds. BIDEN'S NEW DRUG STRATEGY AMPS UP BORDER CONTROL — The president's inaugural drug control strategy being rolled out Thursday will boost efforts to provide addiction care while giving an additional $300 million each to Customs and Border Protection and the Drug Enforcement Administration to crack down on illicit drug trafficking. The Office of National Drug Control Policy aims to double treatment center admissions for the most at-risk users and ensure "universal access to medications for opioid use disorder by 2025," ONDCP Director Rahul Gupta told reporters Wednesday. At the same time, the strategy "is unveiling a renewed focus on disrupting national criminal organizations and their illicit financial networks and supply chains." The new plan lands amid a record high of 106,854 drug overdose deaths in the 12-month period ending in November. That follows a 26.8 percent increase in deaths measured from April 2020 to April 2021. Public health and addiction care advocates point to pandemic isolation and the persistent spread of lethal, powerful fentanyl mixes. A carrot-and-big-stick approach: But many of those same advocates argue that aggressive enforcement can exacerbate black-market activity and fuel a turn to more dangerous drugs like fentanyl. Senior administration officials said increased law enforcement would be balanced with a multipronged effort to increase access to care, syringe-exchange programs and addiction treatments such as naloxone. "It is easier to get illicit drugs than it is to get treatment in this country. We're not going to be able to bend the curve on overdoses until that improves," a senior administration official told reporters. Meanwhile … House Republicans on the Energy and Commerce Committee have asked HHS Secretary Xavier Becerra to examine the reasons for the rise in overdose deaths, saying the government's response to the Covid-19 pandemic is "undoubtedly a large factor." Here's the letter. LOOMING LOSS OF TELEHEALTH ACCESS — Millions of patients are losing expanded access to telehealth across state lines as states' pandemic emergency declarations wind down, POLITICO's Ben Leonard writes. The lifting of state waivers will usher in a return to a pre-pandemic system characterized by more restricted access to telehealth and will exacerbate long-existing provider shortages. Health and Human Services Secretary Xavier Becerra has called on Congress to expand telehealth access across state lines, but the industry is divided over how to fix the issue. Powerful interests, including the American Medical Association and state medical boards, have clashed with the telehealth industry. The Federation of State Medical Boards and the AMA have pushed alternatives to national proposals that would let patients get care in other states if a provider is licensed in one state, arguing a national solution could compromise state boards' ability to oversee providers and ensure patient safety.
|
Comments
Post a Comment